14-53153080-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001160148.2(DDHD1):​c.19G>C​(p.Gly7Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000773 in 1,293,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.7e-7 ( 0 hom. )

Consequence

DDHD1
NM_001160148.2 missense

Scores

4
2
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.162

Publications

1 publications found
Variant links:
Genes affected
DDHD1 (HGNC:19714): (DDHD domain containing 1) This gene is a member of the intracellular phospholipase A1 gene family. The protein encoded by this gene preferentially hydrolyzes phosphatidic acid. It is a cytosolic protein with some mitochondrial localization, and is thought to be involved in the regulation of mitochondrial dynamics. Overexpression of this gene causes fragmentation of the tubular structures in mitochondria, while depletion of the gene results in mitochondrial tubule elongation. Deletion of this gene in male mice caused fertility defects, resulting from disruption in the organization of the mitochondria during spermiogenesis. In humans, mutations in this gene have been associated with hereditary spastic paraplegia (HSP), also known as Strumpell-Lorrain disease, or, familial spastic paraparesis (FSP). This inherited disorder is characterized by progressive weakness and spasticity of the legs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
DDHD1-DT (HGNC:55441): (DDHD1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23198414).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DDHD1NM_001160148.2 linkc.19G>C p.Gly7Arg missense_variant Exon 1 of 13 ENST00000673822.2 NP_001153620.1 Q8NEL9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DDHD1ENST00000673822.2 linkc.19G>C p.Gly7Arg missense_variant Exon 1 of 13 NM_001160148.2 ENSP00000500986.2 Q8NEL9-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.73e-7
AC:
1
AN:
1293154
Hom.:
0
Cov.:
35
AF XY:
0.00000157
AC XY:
1
AN XY:
635288
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25110
American (AMR)
AF:
0.00
AC:
0
AN:
17600
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20240
East Asian (EAS)
AF:
0.0000338
AC:
1
AN:
29576
South Asian (SAS)
AF:
0.00
AC:
0
AN:
65122
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3730
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1043072
Other (OTH)
AF:
0.00
AC:
0
AN:
53448
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia Uncertain:1
Mar 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.055
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0068
.;.;T;.
Eigen
Benign
0.048
Eigen_PC
Benign
-0.098
FATHMM_MKL
Benign
0.18
N
LIST_S2
Uncertain
0.90
D;D;D;D
M_CAP
Pathogenic
0.82
D
MetaRNN
Benign
0.23
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
.;L;L;L
PhyloP100
0.16
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.51
.;N;N;N
REVEL
Benign
0.14
Sift
Pathogenic
0.0
.;D;D;D
Sift4G
Pathogenic
0.0
D;T;T;T
Polyphen
1.0
.;.;D;D
Vest4
0.31
MutPred
0.14
Gain of MoRF binding (P = 0.0176);Gain of MoRF binding (P = 0.0176);Gain of MoRF binding (P = 0.0176);Gain of MoRF binding (P = 0.0176);
MVP
0.082
MPC
0.97
ClinPred
0.70
D
GERP RS
3.7
PromoterAI
0.014
Neutral
Varity_R
0.18
gMVP
0.41
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1052951644; hg19: chr14-53619798; API